MX386586B - Cristal de base libre de derivados benzofurano y método de preparación. - Google Patents

Cristal de base libre de derivados benzofurano y método de preparación.

Info

Publication number
MX386586B
MX386586B MX2019012967A MX2019012967A MX386586B MX 386586 B MX386586 B MX 386586B MX 2019012967 A MX2019012967 A MX 2019012967A MX 2019012967 A MX2019012967 A MX 2019012967A MX 386586 B MX386586 B MX 386586B
Authority
MX
Mexico
Prior art keywords
crystal
preparation
benzofuran
free base
present
Prior art date
Application number
MX2019012967A
Other languages
English (en)
Other versions
MX2019012967A (es
Inventor
Chao Xu
Likun Wang
Qiyun Shao
Zhenxing Du
Original Assignee
Jiangsu Hengrui Medicine Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangsu Hengrui Medicine Co filed Critical Jiangsu Hengrui Medicine Co
Publication of MX2019012967A publication Critical patent/MX2019012967A/es
Publication of MX386586B publication Critical patent/MX386586B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a un cristal de una base libre de derivado de benzofurano y a un método de preparación. Específicamente, la presente invención se refiere al cristal A, cristal B, cristal C y cristal D de N-((4,6-dimetil-2-carbonil-1,2-dihidropiridin-3-il)metil)-5-etilo-6-(etil(tetrahidro-2H-piran)4-il)amino)-2-(piperidin-1-ilmetil)benzofuran-4-carboxamida y un método de preparación para los cristales. Los cristales del compuesto de fórmula (I) de la presente invención tienen una gran estabilidad cristalina y proporcionan usos mejorados en el tratamiento clínico (ver fórmula I).
MX2019012967A 2017-05-18 2018-05-17 Cristal de base libre de derivados benzofurano y método de preparación. MX386586B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201710350574 2017-05-18
PCT/CN2018/087272 WO2018210302A1 (zh) 2017-05-18 2018-05-17 一种苯并呋喃类衍生物游离碱的晶型及制备方法

Publications (2)

Publication Number Publication Date
MX2019012967A MX2019012967A (es) 2020-01-20
MX386586B true MX386586B (es) 2025-03-19

Family

ID=64273357

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019012967A MX386586B (es) 2017-05-18 2018-05-17 Cristal de base libre de derivados benzofurano y método de preparación.

Country Status (11)

Country Link
US (1) US11155537B2 (es)
EP (1) EP3626715A4 (es)
JP (1) JP7257328B2 (es)
KR (1) KR102612379B1 (es)
CN (1) CN109937200B (es)
AU (1) AU2018269268B2 (es)
CA (1) CA3058496A1 (es)
MX (1) MX386586B (es)
MY (1) MY198008A (es)
TW (1) TWI772424B (es)
WO (1) WO2018210302A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202108578A (zh) * 2019-05-10 2021-03-01 大陸商江蘇恒瑞醫藥股份有限公司 6-取代氨基苯并呋喃化合物的製備方法
CN117956995A (zh) * 2021-08-30 2024-04-30 江苏恒瑞医药股份有限公司 一种ezh2抑制剂用于制备治疗t细胞淋巴瘤的药物的用途
MX2024004579A (es) * 2021-10-15 2024-04-30 Jiangsu Hengrui Pharmaceuticals Co Ltd Metodo de preparacion de derivado de benzofurano.
AU2023295387A1 (en) 2022-06-13 2025-01-09 Treeline Biosciences, Inc. 1,8-naphthyridin-2-one heterobifunctional bcl6 degraders
KR20250023483A (ko) 2022-06-13 2025-02-18 트리라인 바이오사이언시스, 인크. 퀴놀론 bcl6 이작용성 분해제
WO2024260368A1 (zh) * 2023-06-19 2024-12-26 江苏恒瑞医药股份有限公司 一种苯并呋喃衍生物及其中间体的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012005805A1 (en) 2010-05-07 2012-01-12 Glaxosmithkline Llc Azaindazoles
US8846935B2 (en) 2010-05-07 2014-09-30 Glaxosmithkline Llc Indazoles
SG180031A1 (en) 2010-10-15 2012-05-30 Agency Science Tech & Res Combination treatment of cancer
WO2012118812A2 (en) * 2011-02-28 2012-09-07 Epizyme, Inc. Substituted 6,5-fused bicyclic heteroaryl compounds
JO3363B1 (ar) 2011-04-13 2019-03-13 Epizyme Inc مركبات بنزين مستبدلة بأريل أو أريل غير متجانس
TW201733984A (zh) 2011-04-13 2017-10-01 雅酶股份有限公司 經取代之苯化合物
US9073924B2 (en) 2011-09-13 2015-07-07 Glaxosmithkline Llc Azaindazoles
US9730925B2 (en) 2011-09-30 2017-08-15 Glaxomithkline Llc Methods of treating cancer
WO2013067300A1 (en) 2011-11-04 2013-05-10 Glaxosmithkline Intellectual Property (No. 2) Limited Method of treatment
UA111305C2 (uk) 2012-12-21 2016-04-11 Пфайзер Інк. Конденсовані лактами арилу та гетероарилу
PL3121175T3 (pl) 2014-03-17 2020-06-01 Daiichi Sankyo Company, Limited Pochodne 1,3-benzodioksolu jako inhibitory ezh1 i/lub ezh2
SI3378859T1 (sl) * 2015-11-19 2020-03-31 Jiangsu Hengrui Medicine Co., Ltd., Derivat benzofurana, postopek za njegovo pripravo in njegova uporaba v medicini

Also Published As

Publication number Publication date
MY198008A (en) 2023-07-25
CN109937200B (zh) 2020-09-11
EP3626715A1 (en) 2020-03-25
JP2020519569A (ja) 2020-07-02
US20210130333A1 (en) 2021-05-06
RU2019136363A (ru) 2021-06-18
MX2019012967A (es) 2020-01-20
KR102612379B1 (ko) 2023-12-12
CA3058496A1 (en) 2018-11-22
BR112019021023A2 (pt) 2020-05-05
TWI772424B (zh) 2022-08-01
US11155537B2 (en) 2021-10-26
AU2018269268A1 (en) 2019-11-07
RU2019136363A3 (es) 2021-12-29
JP7257328B2 (ja) 2023-04-13
KR20200006551A (ko) 2020-01-20
EP3626715A4 (en) 2021-03-24
AU2018269268B2 (en) 2022-01-06
TW201900639A (zh) 2019-01-01
WO2018210302A1 (zh) 2018-11-22
CN109937200A (zh) 2019-06-25

Similar Documents

Publication Publication Date Title
JOP20250289A1 (ar) صور بلورية جديدة
MY198008A (en) Crystal of benzofuran derivative free base and preparation method
EA202090688A1 (ru) Бис-амидные соединения, активирующие саркомер, и варианты их применения
MX383856B (es) Compuestos y composiciones para inhibir la actividad de shp2.
EA201890450A1 (ru) Циклические динуклеотидные соединения в качестве агонистов sting
EA201891191A1 (ru) 2-замещенные соединения хиназолина, содержащие замещенную гетероциклическую группу, и способы их применения
EA201691401A1 (ru) Индазольные соединения в качестве ингибиторов irak4
EA201691428A1 (ru) Бициклические гетероциклические производные в качестве ингибиторов irak4
JOP20190174B1 (ar) مثبطات jak1 انتقائية
EA201492023A1 (ru) Регуляторы пути комплемента и их применение
EP4324525A3 (en) Hydrochloride salt form for ezh2 inhibition
CL2014003181A1 (es) Compuestos derivados de benzamidas n- sustituidas o piridinamidas n-sustituidas; composicion farmaceutica que los comprende; metodo de tratamiento; y su uso para el tratamiento de enfermedades o trastornos seleccionados de dolor, depresion y enfermedades cardiovasculares, respiratorias o psiquiatricas o combinaciones de estas.
EA201491824A1 (ru) Производные бензамида для ингибирования активности abl1, abl2 и bcr-abl1
EA201990388A1 (ru) Пиперидиновые модуляторы рецепторов cxcr7
TN2018000106A1 (en) Farnesoid x receptor modulators
JO3430B1 (ar) مشتقات حمض أميني جديدة، عملية لتحضيرها وتركيبات صيدلية تحتوي عليها
PH12015502192A1 (en) Novel compounds
EA201790246A1 (ru) Гетероциклические карбоновые кислоты в качестве активаторов растворимой гуанилатциклазы
EA201391288A1 (ru) Производные пиразолоспирокетонов для применения в качестве ингибиторов ацетил-коа-карбоксилаз
EA201300436A8 (ru) Совместные кристаллы и соли ингибиторов ccr3
BR112019003320A2 (pt) compostos de heteroaril carboxamida como inibidores de ripk2
TN2019000204A1 (en) Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
CY1121484T1 (el) Μορφες αλατος και κρυσταλλου ενος αναστολεα plk-4
JOP20190050A1 (ar) مثبطات دوبامين-b-هيدروكسيلاز تخترق حاجز المخ الدموي
EA201890532A1 (ru) Новые аннелированные бензамиды